Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies to treat autoimmune disease
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies to treat autoimmune disease. The company is focused on harnessing the body's natural killer cells to deliver a safe, accessible form of cell therapy for B cell-mediated autoimmune diseases.